COMP <GO>
STAA vs RXST // EV/EBITDA & P/E VALUATION
STAAR Surgical Company (NASDAQ) VS. RxSight Inc. (NASDAQ) • 15-METRIC TALLY: STAA 5
— RXST 5
■ METRIC PARITY
LAST: $25.24 (+2.56%) • MKT CAP: $1.27B
valuation
—
LAST: $5.05 (+3.06%) • MKT CAP: $210.0M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STAA VS. RXST)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STAA | RXST | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 76.20% | 76.60% | -0.40 | RXST | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -14.90% | -20.10 | RXST | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.16% | -9.21% | +6.05 | STAA | /fcf-yield <GO> |
| Operating Margin | -38.30% | -35.80% | -2.50 | RXST | /operating-margins <GO> |
| Net Profit Margin | -33.60% | 0.00% | -33.60 | RXST | /net-margins <GO> |
| Revenue Growth (YoY) | -23.70% | -3.90% | -19.80 | RXST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.11 | 1.45 | +5.66 | STAA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | STAA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.8 | 46.6 | +15.19 | STAA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.27B | $210.0M | $1.06B | STAA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STAA REV | RXST REV | STAA GROSS % | RXST GROSS % | STAA FCF | RXST FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $239.4M | $134.5M | 76.2% | 76.6% | -$40.0M | -$19.3M |
| FY 2024 | $313.9M | $139.9M | 76.3% | 70.7% | -$7.7M | -$22.4M |
| FY 2023 | $322.4M | $89.1M | — | — | $14.6M | -$41.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STAA // BETA —
RXST // BETA —